Varenzin-CA1 Molidustat Oral Suspension

Varenzin-CA1 is a molidustat oral suspension for cats. Its US reference describes conditional approval for non-regenerative anaemia associated with chronic kidney disease, making blood monitoring central to its clinical role.

Supporting the body’s red-cell pathway

Molidustat inhibits hypoxia-inducible-factor prolyl hydroxylase, often abbreviated HIF-PH. The reference mechanism supports signalling involved in the body’s erythropoietin response. It is an anaemia medicine with a defined clinical purpose, rather than a substitute for every renal-care product.

The 27 mL oral suspension

The listed bottle contains 25 mg/mL molidustat sodium in a 27 mL presentation. Concentration and total bottle volume identify the liquid together. A 25 mg tablet is a different formulation and cannot be treated as the same pack by comparing the number 25.

Monitoring is part of the treatment

Veterinary blood checks assess the response and help guide the course of treatment. A kidney diagnosis alone does not determine whether the cat needs an anaemia medicine. Ask which monitoring appointments and product-handling instructions belong to the prescribed plan.

A clearly recorded liquid routine

Use the exact label, measuring instructions and prescribed concentration. Keep the product and measuring device identified for this animal. Record the named liquid on refill enquiries so it is not confused with another molidustat tablet or a different market presentation.